We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Panel Recommends Expanding Crestor Use
FDA Advisory Panel Recommends Expanding Crestor Use
December 15, 2009
An FDA advisory panel has voted to recommend that the agency approve expanded use of AstraZeneca’s Crestor to prevent cardiovascular disease but
urged patient monitoring for signs of diabetes, a CDER official says.